Authors: Giolitti, A Cucchi, P Renzetti, AR Rotondaro, L Zappitelli, S Maggi, CA

Citation: A. Giolitti et al., Molecular determinants of peptide and nonpeptide NK-2 receptor antagonistsbinding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis, NEUROPHARM, 39(8), 2000, pp. 1422-1429

Authors: Giannotti, D Perrotta, E Di Bugno, C Nannicini, R Harmat, NJS Giolitti, A Patacchini, R Renzetti, AR Rotondaro, L Giuliani, S Altamura, M Maggi, CA

Citation: D. Giannotti et al., Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists, J MED CHEM, 43(22), 2000, pp. 4041-4044

Authors: Renzetti, AR Catalioto, RM Criscuoli, M Cucchi, P Ferrer, C Giolitti, A Guelfi, M Rotondaro, L Warner, FJ Maggi, CA

Citation: Ar. Renzetti et al., Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK2 receptor, J PHARM EXP, 290(2), 1999, pp. 487-495

Authors: Renzetti, AR Catalioto, RM Carloni, C Criscuoli, M Cucchi, P Giolitti, A Zappitelli, S Rotondaro, L Maggi, CA

Citation: Ar. Renzetti et al., Effects of tyrosine289phenylalanine mutation on binding and functional properties of the human tachykinin NK2 receptor stably expressed in Chinese hamster ovary cells, BIOCH PHARM, 57(8), 1999, pp. 899-906